Cancer News and Research

Latest Cancer News and Research

Innovative research project explores impact of healthy weight and lifestyle in breast cancer survivors

An innovative, yearlong research project to determine whether a healthy weight and lifestyle can improve the quality of life for breast cancer survivors is underway at a Topeka, Kansas cancer center.

1 Sep 2015

Jersey Shore to break ground on HOPE Tower to provide new healing outpatient experience for the community

Jersey Shore University Medical Center, part of the Meridian Health family, is preparing to break ground this fall on the HOPE Tower Project - a $265 million dollar building development on the hospital's east campus that will provide a new healing outpatient experience for the community. HOPE Tower's expected date of completion is early 2018.

1 Sep 2015

Multiple HIV-1 variants at the beginning of infection impact viral load setpoints

HIV-1 infection with multiple founder variants points to poorer clinical outcomes than infection with a single variant, according to a paper published today in the journal Nature Medicine.

1 Sep 2015

Bionomics submission of BNC101 IND for cancer treatment passes FDA review

Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today announced that its BNC101 IND submission has passed review by the US Food and Drug Administration (FDA).

31 Aug 2015

Regen BioPharma develops novel means of delivering RGBP-248 gene silencing nucleic acid to liver tumors

Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.

31 Aug 2015

Soligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in cancer patients

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today it has completed enrollment of the additional subjects, as directed by the Data Review Committee (DRC) earlier this year, into the company's Phase 2 study for SGX942.

31 Aug 2015

Prolonged television watching associated with twice the risk of fatal pulmonary embolism

Prolonged television watchers have a higher risk of fatal pulmonary embolism, a condition associated with long haul flights, reveals research presented at ESC Congress today by Mr Toru Shirakawa, public health research fellow in the Department of Social Medicine at Osaka University in Japan.

31 Aug 2015

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

31 Aug 2015

Scientists discover the oldest case of leukemia in prehistoric female skeleton

Scientists of the Senckenberg Center for Human Evolution and Paleoenvironment and the University of Tübingen have discovered what may well be the oldest known case of Leukemia.

31 Aug 2015

CytomX announces filing of registration statement for proposed initial public offering of common stock

CytomX Therapeutics, Inc., a biopharmaceutical company developing Probody therapeutics for the treatment of cancer, today announced the filing of a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock.

29 Aug 2015

Brain tumor is not always the death sentence

Only half of brain cancers actually start in the brain. The rest - as in the case of former president Jimmy Carter - are metastatic tumors from cancer that originated elsewhere in the body.

29 Aug 2015

Fentanyl sold as heroin causing new wave of overdose deaths

With the heroin epidemic in the United States reaching deadlier heights, Jacksonville-based Lakeview Health drug and alcohol treatment center's Dr. Philip Hemphill is helping to explain why fentanyl is causing a new wave of overdoses. Because Fentanyl is approximately 40 to 50 times more potent than pharmaceutical grade heroin and often illegally purchased unknowingly by recreational users as heroin, the risk of death skyrockets.

29 Aug 2015

Synthetic tissue environment enables spatial definition of cancer cells and macrophages

Tumors are notoriously difficult to study in their natural habitat - body tissues - but a new synthetic tissue environment may give cancer researchers the next-best look at tumor growth and behavior.

29 Aug 2015

New ESC Guidelines on infective endocarditis support role of imaging in diagnosis

ESC Guidelines published today on infective endocarditis boost the role of imaging in diagnosis of this deadly disease.

29 Aug 2015

University of Huddersfield researchers develop new device to improve quality of care for young cancer patients

A DEVICE, developed through a collaboration by a team at the University of Huddersfield and a local charity, is set to improve the quality of care for child cancer patients. Medical practitioners and a dedicated charity have signalled that they are highly impressed by the design for a special harness, that safely and comfortably, contains the tubing inserted into the chests of youngsters during treatment.

29 Aug 2015

Novel chemical virus can cross double lipid layer surrounding cells to release drugs

Viruses are able to redirect the functioning of cells in order to infect them. Inspired by their mode of action, scientists from the CNRS and Université de Strasbourg have designed a "chemical virus" that can cross the double lipid layer that surrounds cells, and then disintegrate in the intracellular medium in order to release active compounds.

29 Aug 2015

Keratin 17 protein plays crucial role in degrading key tumor suppressor protein

Keratin 17 (K17), a protein previously believed to provide only mechanical support for cancer cells, appears to play a crucial role in degrading a key tumor suppressor protein in cancer cells named p27. This finding, published in the September 1 issue of Cancer Research, is based on the work of researchers in the Department of Pathology at Stony Brook University School of Medicine.

29 Aug 2015

Cancer News and Research

Latest Cancer News and Research

Innovative research project explores impact of healthy weight and lifestyle in breast cancer survivors

Jersey Shore to break ground on HOPE Tower to provide new healing outpatient experience for the community

Multiple HIV-1 variants at the beginning of infection impact viral load setpoints

Bionomics submission of BNC101 IND for cancer treatment passes FDA review

Regen BioPharma develops novel means of delivering RGBP-248 gene silencing nucleic acid to liver tumors

Soligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in cancer patients

Prolonged television watching associated with twice the risk of fatal pulmonary embolism

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Scientists discover the oldest case of leukemia in prehistoric female skeleton

CytomX announces filing of registration statement for proposed initial public offering of common stock

Brain tumor is not always the death sentence

Fentanyl sold as heroin causing new wave of overdose deaths

Synthetic tissue environment enables spatial definition of cancer cells and macrophages

New ESC Guidelines on infective endocarditis support role of imaging in diagnosis

University of Huddersfield researchers develop new device to improve quality of care for young cancer patients

Novel chemical virus can cross double lipid layer surrounding cells to release drugs

Keratin 17 protein plays crucial role in degrading key tumor suppressor protein

Fetal microchimerism could be a subtle and dizzyingly complex puzzle

OU and Mercy receive $2.5 million grant to develop new short-term breast cancer risk prediction models

Moffitt researchers hope to improve pancreatic cancer survival rates by developing blood test to identify IPMNs

Industry Focus eBook - Oncology (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in